News | November 01, 2023
Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Marking a significant milestone in its commitment to holistic wellness
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
